CS logo
small CS logo
Clinical Research Institute of Southern Oregon, PC

Medford, Oregon, United States
Research institute in Medford, Oregon
3860 Crater Lake Ave, Medford, OR 97504

About Clinical Research Institute of Southern Oregon, PC


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Clinical Research Institute of Southern Oregon, PC


During the past decade, Clinical Research Institute of Southern Oregon, PC conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 18 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 8 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
2001-04-01
2004-12-01
Completed
600
Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
2004-03-01
Completed
383
Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
2005-01-01
2008-08-01
Completed
151
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
2005-03-01
2018-08-01
Completed
4,216
A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
2004-03-14
2009-12-23
Completed
49
A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
2005-10-01
2007-09-01
Completed
298
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
2005-12-01
2014-09-01
Completed
4,172
PhII ICb With/Without Erbitux in MBC Pts
2005-07-28
2022-12-01
Active, not recruiting
154

Rows per page:

1–100 of 122

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Clinical Research Institute of Southern Oregon, PC" #1 sponsor was "Pfizer" with 8 trials, followed by "Sunovion" with 6 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Sunovion Respiratory Development Inc." with 4 trials sponsored and "Chiesi Farmaceutici S.p.A." with 4 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 37 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Institute of Southern Oregon, PC" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "Cephalon" with 1 trials as a collaborator, "Chiesi USA, Inc." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Clinical Research Institute of Southern Oregon, PC


According to Clinical.Site data, the most researched conditions in "Clinical Research Institute of Southern Oregon, PC" are "Asthma" (16 trials), "Atopic Dermatitis" (7 trials), "Chronic Obstructive Pulmonary Disease" (7 trials), "COPD" (4 trials) and "Perennial Allergic Rhinitis" (4 trials). Many other conditions were trialed in "Clinical Research Institute of Southern Oregon, PC" in a lesser frequency.

Clinical Trials Intervention Types at Clinical Research Institute of Southern Oregon, PC


Most popular intervention types in "Clinical Research Institute of Southern Oregon, PC" are "Drug" (55 trials), "Biological" (15 trials) and "Other" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (32 trials), "Lebrikizumab" (5 trials), "placebo" (5 trials), "0.15% azelastine hydrochloride" (2 trials) and "Ciclesonide nasal aerosol 37 mcg" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Clinical Research Institute of Southern Oregon, PC


The vast majority of trials in "Clinical Research Institute of Southern Oregon, PC" are 69 trials for "All" genders.

Clinical Trials Status at Clinical Research Institute of Southern Oregon, PC


Currently, there are NaN active trials in "Clinical Research Institute of Southern Oregon, PC". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Clinical Research Institute of Southern Oregon, PC, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Clinical Research Institute of Southern Oregon, PC, 1 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status